Literature DB >> 28112991

Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.

Ishveen Chopra1, Kimberly M Kelly1,2.   

Abstract

Genetic counseling and testing for familial cancer is a unique context for the communication of risk information in the family. This study utilized a theoretical framework based on the family systems perspective to understand intrafamilial cancer risk communication patterns in the Ashkenazi Jewish population. Individuals (n = 120) at an elevated risk for BRCA1/2 mutations were included. Change in communication patterns over time was assessed using McNemar tests. Associations with communication patterns were assessed with multivariable logistic regression. Overall, the proportion of participants encouraged by others significantly (p < .001) increased from before to after genetic counseling. A higher proportion of participants were encouraged by female family members compared with male family members. Participants who were older, had no personal history of cancer, and had a higher cancer risk perception were more likely to be encouraged by others for genetic testing. Participant's intent to encourage family members for genetic testing from before counseling to after receipt of genetic test results decreased by 16.7%. Participants who had no personal history of cancer and had informative test results for a BRCA1/2 mutation were more likely to encourage other family members for genetic testing. In addition, qualitative findings suggested that closeness among family members, concern for family, especially future generations, and cognizance about cancer risk facilitate information sharing and encouragement for genetic testing. Our findings indicate that intrafamilial cancer risk communication varies with the structure of family relationships and that genetic counseling can play an important role in improving intrafamilial cancer risk communication.

Entities:  

Mesh:

Year:  2017        PMID: 28112991      PMCID: PMC5586537          DOI: 10.1080/10810730.2016.1258743

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  30 in total

Review 1.  Family communication about genetic risk: the little that is known.

Authors:  Brenda J Wilson; Karen Forrest; Edwin R van Teijlingen; Lorna McKee; Neva Haites; Eric Matthews; Sheila A Simpson
Journal:  Community Genet       Date:  2004

Review 2.  Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information.

Authors:  Gillian Nycum; Denise Avard; Bartha M Knoppers
Journal:  Eur J Hum Genet       Date:  2009-03-25       Impact factor: 4.246

3.  ASHG statement. Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure.

Authors: 
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

4.  Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior.

Authors:  C Lerman; K Kash; M Stefanek
Journal:  J Natl Cancer Inst Monogr       Date:  1994

5.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

6.  Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study.

Authors:  Rahul Garg; Joseph Vogelgesang; Kimberly Kelly
Journal:  J Genet Couns       Date:  2015-11-18       Impact factor: 2.537

7.  Effects of individual and family functioning on interest in genetic testing.

Authors:  Deborah J Bowen; Emily Bourcier; Nancy Press; Frances M Lewis; Wylie Burke
Journal:  Community Genet       Date:  2004

8.  We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC).

Authors:  Regina Kenen; Audrey Arden-Jones; Rosalind Eeles
Journal:  Psychooncology       Date:  2004-05       Impact factor: 3.894

9.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention.

Authors:  Jan M Hodgson; Sylvia A Metcalfe; Maryanne Aitken; Susan M Donath; Clara L Gaff; Ingrid M Winship; Martin B Delatycki; Loane L C Skene; Belinda J McClaren; Jean L Paul; Jane L Halliday
Journal:  BMC Med Genet       Date:  2014-03-14       Impact factor: 2.103

View more
  10 in total

1.  Update on multi-gene panel testing and communication of genetic test results.

Authors:  Sonya Reid; Tuya Pal
Journal:  Breast J       Date:  2020-07-08       Impact factor: 2.431

2.  The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer.

Authors:  Claire C Conley; Dana Ketcher; Maija Reblin; Monica L Kasting; Deborah Cragun; Jongphil Kim; Kimlin Tam Ashing; Cheryl L Knott; Chanita Hughes-Halbert; Tuya Pal; Susan T Vadaparampil
Journal:  J Genet Couns       Date:  2020-01-07       Impact factor: 2.537

Review 3.  A systematic review of theory-informed strategies used in interventions fostering family genetic risk communication.

Authors:  Jingsong Zhao; Yue Guan; Colleen M McBride
Journal:  Patient Educ Couns       Date:  2022-03-11

4.  An in-depth exploration of the post-test informational needs of BRCA1 and BRCA2 pathogenic variant carriers in Asia.

Authors:  Jeanette Yuen; Si Ming Fung; Chin Leong Sia; Mallika Venkatramani; Tarryn Shaw; Eliza Courtney; Shao-Tzu Li; Jianbang Chiang; Veronique Kiak-Mien Tan; Benita Kiat-Tee Tan; Joanne Ngeow
Journal:  Hered Cancer Clin Pract       Date:  2020-10-23       Impact factor: 2.857

5.  Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.

Authors:  Fatima Al Hannan; Michael B Keogh; Safa Taha; Latifa Al Buainain
Journal:  Mol Genet Genomic Med       Date:  2019-05-26       Impact factor: 2.183

6.  Feasibility of genetic testing for cancer risk assessment programme in Nigeria.

Authors:  Prisca O Adejumo; Toyin I G Aniagwu; Olutosin A Awolude; Abiodun O Oni; Olubunmi O Ajayi; Omolara Fagbenle; Dasola Ogungbade; Makayla Kochheiser; Temidayo Ogundiran; Olufunmilayo I Olopade
Journal:  Ecancermedicalscience       Date:  2021-09-07

7.  Sex Differences in Attitudes Toward Marriage and Childbearing Based on the Assumption of Being BRCA1/2 Mutation Carriers Among Young People.

Authors:  Jiwon Jeong; Boyoung Park; Dongwon Kim; Jiyoung Kim; Bom-Yi Lee; Junghyun Yoon; Sung-Won Kim
Journal:  J Breast Cancer       Date:  2022-06       Impact factor: 2.922

8.  Public Interest in Population Genetic Screening for Cancer Risk.

Authors:  Megan C Roberts; Kimberly S Foss; Gail E Henderson; Sabrina N Powell; Katherine W Saylor; Karen E Weck; Laura V Milko
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

9.  The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer.

Authors:  Carla Pedrazzani; Monica Aceti; Reka Schweighoffer; Andrea Kaiser-Grolimund; Nicole Bürki; Pierre O Chappuis; Rossella Graffeo; Christian Monnerat; Olivia Pagani; Manuela Rabaglio; Maria C Katapodi; Maria Caiata-Zufferey
Journal:  J Pers Med       Date:  2022-07-29

10.  Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!

Authors:  Hikmat Abdel-Razeq
Journal:  Oncol Rev       Date:  2021-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.